MR编号 | NL/H/4935/001 |
---|
药品名称 | Megapar Plus 500 mg/8 mg/30 mg bruistablet |
---|
活性成分 | - Caffeine 30.0 mg
- Codeine phosphate 8.0 mg
- Paracetamol 500.0 mg
|
---|
剂型 | Effervescent tablet |
---|
上市许可持有人 | Accor Healthcare S.L.U.
Edificio Este planta 6
World Trade Center
Moll de Barcalona S/N |
---|
参考成员国 - 产品名称 | Netherlands (NL) |
---|
互认成员国 - 产品名称 | - Germany (DE)
- Belgium (BE)
- United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Austria (AT)
- France (FR)
- Portugal (PT)
- Italy (IT)
- Greece (GR)
- Sweden (SE)
- Finland (FI)
- Poland (PL)
- Latvia (LV)
- Lithuania (LT)
- Estonia (EE)
- Hungary (HU)
- Bulgaria (BG)
- Cyprus (CY)
- Czechia (CZ)
- Romania (RO)
- Slovakia (SK)
- Slovenia (SI)
- Malta (MT)
- Croatia (HR)
|
---|
许可日期 | 2021/12/07 |
---|
最近更新日期 | 2024/12/12 |
---|
药物ATC编码 | - N02AJ06 codeine and paracetamol
|
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|